Public annual accounts

NORDIC PHARMA financials

Name: NORDIC PHARMA financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for NORDIC PHARMA, with comparable measures and links to available source documents.

Company overview

Registry number

0892926867

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 27, 2026

Financial evidence

Latest movements for NORDIC PHARMA

2025 versus 2024

Operating line: €647,877
Total assets: €1,327,631
Equity: €232,812

Equity ratio +17.5%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€647,877	-	€1,327,631	€232,812	-
202431 Dec 2024	€552,546	-	€1,137,894	-€154,433	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report